NCM
ADAP

Narwhal Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Narwhal Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,344
Closed -$9.57K – 164
2023
Q2 		$9.57K Hold
10,344
– – ﹤0.01% 169
2023
Q1 		$11.3K Hold
10,344
– – ﹤0.01% 162
2022
Q4 		$15.1K Hold
10,344
– – ﹤0.01% 158
2022
Q3 		$11K Buy
+10,344
New +$11K ﹤0.01% 149